Mayo Clinic
Mayo Clinic was founded in 1889 and is known as a preeminent research and medical treatment institution. The Mayo Clinic at Rochester employs over 30,000 people. Mayo Clinic is known for leading edge Biomedical imaging, diagnosis and treatment as well as cutting edge patient and professional education. Mayo Clinic has expanded to the Phoenix, Arizona and Jacksonville, Florida area where it offers treatment and research services. Today, Mayo Clinic employs over 3,500 physicians and more than 3,000 research personnel.
Young children exposed to anesthesia multiple times show elevated rates of ADHD
Mayo Clinic researchers have found that multiple exposures to anesthesia at a young age are associated with higher rates of attention-deficit/hyperactivity disorder (ADHD).
Medicine & Health / Psychology & Psychiatry
Feb 02, 2012 |
5 / 5 (3) |
0
First-of-its-kind head patch monitors brain blood flow and oxygen
A research team led by investigators at Mayo Clinic in Florida has found that a small device worn on a patient's brow can be useful in monitoring stroke patients in the hospital. The device measures blood oxygen, similar ...
Medicine & Health / Cardiology
Feb 01, 2012 |
not rated yet |
0
Mayo Clinic releases book with action plan to help beat heart disease
Heart disease is the nation's No. 1 killer for both men and women. But what's most astonishing is that almost 80 percent of heart disease is preventable, and even small lifestyle changes can have a big impact.
Jan 30, 2012 |
4.5 / 5 (2) |
0
New test offers greater accuracy in early detection of colorectal cancer
Results of two studies suggest that a new, investigational colorectal cancer screening test developed in a collaboration between Mayo Clinic and Exact Sciences Inc. of Madison, Wis., is highly accurate and significantly more ...
Jan 19, 2012 |
not rated yet |
0
Drug improves survival of colorectal cancer patients, trial results show
An investigational drug called regorafenib slowed the progression of tumors and lengthened the lives of patients with metastatic colorectal cancer, an international phase III clinical trial found. The findings were presented ...
Jan 18, 2012 |
not rated yet |
0
Studies identify risk factors in rising trend of liver cancer
Doctors have known for years that the incidence of deadly liver cancer is on the rise, but what is causing that trend has remained a mystery. Two recent Mayo Clinic studies published in the January issue of Mayo Clinic Pr ...
Jan 03, 2012 |
4 / 5 (1) |
0
'Rare' brain disorder may be more common than thought: study
A global team of neuroscientists, led by researchers at Mayo Clinic in Florida, have found the gene responsible for a brain disorder that may be much more common than once believed. In the Dec. 25 online issue of Nature Ge ...
Dec 25, 2011 |
4.7 / 5 (7) |
0
|
Obesity linked to higher 5-year death rate after esophageal cancer surgery
Obesity doubles the risk of cancer recurrence and cancer-related death in patients with esophageal cancer who have been treated with surgery, researchers at Mayo Clinic found. Their 778-patient study, which appeared in the ...
Dec 20, 2011 |
not rated yet |
0
Angioplasties performed at centers without on-site surgery services are safe, study finds
Contrary to current guidelines, Mayo Clinic researchers have found that angioplasties performed at centers without on-site cardiac surgery capabilities pose no increased risk for patient death or emergency bypass surgery. ...
Dec 13, 2011 |
not rated yet |
0
Ruxolinitib better at reducing myelofibrosis symptoms, study shows
In a major advance in treatment, a multicenter study found that ruxolinitib did a better job than off-label chemotherapy drugs reducing the terrible symptoms associated with myelofibrosis, including pain, enlarged spleen, anemia, fever, chills ...
Dec 12, 2011 |
not rated yet |
0
How patients will respond to immunomodulator therapy for multiple myeloma
Research on the same protein that was a primary mediator of the birth defects caused by thalidomide now holds hope in the battle against multiple myeloma, says the study's senior investigator, Keith Stewart, M.B., Ch.B. of ...
Dec 11, 2011 |
5 / 5 (1) |
0
Proteins do not predict outcome of herceptin treatment in HER2-positive breast cancer
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2-Positive Breast Cancer ...
Dec 09, 2011 |
not rated yet |
0
Obese patients with HER2-positive breast cancer may have worse outcomes
Obese patients with early-stage HER2-positive breast cancer may have worse outcomes than patients who are normal weight or overweight, Mayo Clinic researchers found in a study presented today at the 2011 CTRC-AACR San Antonio Breast Ca ...
Dec 08, 2011 |
not rated yet |
0
Multiple sclerosis often starts in brain's outer layers: study
Multiple sclerosis (MS) may progress from the outermost layers of the brain to its deep parts, and isn't always an "inside-out" process as previously thought, reported a new collaborative study from researchers at the Mayo ...
Dec 07, 2011 |
5 / 5 (1) |
0
|
Researchers find drug duo kills chemotherapy-resistant ovarian cancer cells
The use of two drugs never tried in combination before in ovarian cancer resulted in a 70 percent destruction of cancer cells already resistant to commonly used chemotherapy agents, say researchers at Mayo Clinic in Florida. ...
Dec 07, 2011 |
not rated yet |
0
